4.5.2 Centrally acting appetite suppressants

Homepage

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

BNF Category

66 library items in 4.5.2 Centrally acting appetite suppressants

Filter results by:

Date Published

NeLM Area

News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies

Results filtered by:

Category

4: Central nervous system (remove) , 4.5 Drugs used in the treatment of obesity (remove) , 4.5.2 Centrally acting appetite suppressants (remove)

Sort by: Display summary:

Results 1 - 10 of 66

Result page:
Previous
|
1
2
3
4
5
6
7
|
Next

1.

FDA advisers support approval of obesity treatment Qnexa (phentermine and topiramate)

Source: Reuters Health News,
Date published: 23/02/2012

Category:

4.5.2 Centrally acting appetite suppressants | Food &Drug Administration (FDA) | New drugs | Obesity

NeLM Area:

News

Link- subscribers only
2.

MHRA warns public against buying dangerous herbal slimming aids online

Source: MHRA,
Date published: 12/08/2011

Category:

4.5.2 Centrally acting appetite suppressants | Adverse Drug Reactions | IT | Medicines and Healthcare products Regulatory Agency (MHRA) | Patient

NeLM Area:

News

Press release
3.

Topiramate exposure and birth defect data to be presented at conference

Source: BioSpace ,
Date published: 21/07/2011

Category:

4.5.2 Centrally acting appetite suppressants | 4.8.1 Control of epilepsy | Drugs in pregnancy | Ear, Nose and Throat (ENT) disorders | Epilepsy | Food &Drug Administration (FDA) | Obesity

NeLM Area:

News

BioSpace

Link to NeLM report of FDA warning (Topamax)

Link to NeLM report on QNEXA
4.

Phase III data suggest weight loss efficacy of combination of SR naltrexone and bupropion in women

Source: Reuters Health News,
Date published: 09/05/2011

Category:

4.5.2 Centrally acting appetite suppressants | Food &Drug Administration (FDA) | New drugs | Obesity

NeLM Area:

News

Link- registration required

NeLM report of phase III study
5.

RCT: Low-dose, controlled-release, phentermine plus topiramate in overweight and obese adults (CONQUER)

Source: Lancet, PharmaTimes,
Date published: 11/04/2011

Category:

4.5.2 Centrally acting appetite suppressants | 4.8 Antiepileptic drugs | European Agency for the Evaluation of Medicinal Products (EMEA) | Food &Drug Administration (FDA) | New drugs | Obesity

NeLM Area:

News

Lancet abstract

PharmaTimes story- registration required

NHS Choices 'Behind the Headlines' assessment
6.

Case report: Rhabdomyolysis associated with phentermine

Source: American Journal of Health-System Pharmacy,
Date published: 08/11/2010

Category:

4.5.2 Centrally acting appetite suppressants | Adverse Drug Reactions | Obesity

NeLM Area:

News

Abstract
7.

MHRA issues warning over unlicensed herbal Payouji tea and Pai You Guo Slim capsules containing sibutramine

Source: MHRA,
Date published: 21/10/2010

Category:

4.5.2 Centrally acting appetite suppressants | Adverse Drug Reactions | Complementary Medicine | Medicines and Healthcare products Regulatory Agency (MHRA)

NeLM Area:

News

MHRA press release

BBC Health news report

'Behind the Headlines' assessment (added 25/10/10)
8.

Use of Sibutramine in pregnancy

Source: UK Teratology Information Service,
Date published: 20/10/2010

Category:

4.5.2 Centrally acting appetite suppressants | Drugs in pregnancy

NeLM Area:

Evidence > Drugs in Pregnancy
9.

Sibutramine withdrawn from US market following FDA recommendation

Source: FDA,
Date published: 11/10/2010

Category:

4.5.2 Centrally acting appetite suppressants | Adverse Drug Reactions | Food &Drug Administration (FDA) | Obesity

NeLM Area:

News

FDA media report

FDA Drug Safety communication

FDA Medwatch Announcement
10.

Sibutramine treatment increases risk of cardiovascular outcomes in high-risk patients

Source: New England Journal of Medicine,
Date published: 07/09/2010

Category:

4.5.2 Centrally acting appetite suppressants | Adverse Drug Reactions | Cardiovascular Medicine | Obesity

NeLM Area:

News

Abstract

Editorial

Results 1 - 10 of 66

Result page:
Previous
|
1
2
3
4
5
6
7
|
Next